Skip to main content

Using Low Dose Naltrexone To Help SIBO Patients

Speaker

Mona Morstein ND

SIBO, small intestine bacterial overgrowth, is estimated to account for up to 60% of all IBS patients.  That’s millions of patients.  The core etiology of developing SIBO is due to auto-immune damage to the nerves that stimulate the muscles of the small gut to move contents forward.  As a result, the colon backwashes bacteria/archae into the small gut and they proliferate, causing significant symptoms and damage to the small gut lining.   Low Dose Naltrexone can be an invaluable tool in working with SIBO patients.  It can help reduce the auto-immunity and acts as a gentle prokinetic, helping to move contents forward to prevent SIBO recurrence.  Learn about SIBO, auto-immunity, prokinetics at this interesting lecture by a SIBO expert." 

  1. Define SIBO as a common gastrointestinal practice
  2. Describe physiology of SIBO
  3. Review prokinetic treatment in SIBO 
  4. Explain use of LDN in SIBO patients
  1. What is SIBO: definition and statistics
  2. Physiology of SIBO: Auto-immunity and poor movement of small gut 
  3. Low Dose Naltrexone in use of SIBO
  4. Dosing of LDA
  5. Side-Effects of LDA
  6. Summary of SIBO and LDN